Literature DB >> 10924729

Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study.

M Y Tsai1, D K Arnett, J H Eckfeldt, R R Williams, R C Ellison.   

Abstract

Mildly elevated plasma total homocysteine (tHcy) levels have been associated with increased risk of coronary heart disease (CHD). Carotid artery intimal-medial wall thickening is a predictor of cardiovascular disease and has been previously shown to be positively associated with plasma tHcy in studies of asymptomatic subjects. In the current study we examined 1467 subjects with regard to their fasting plasma tHcy levels and intimal-medial wall thickness as measured by B-mode ultrasound and early onset CHD. The results showed that there is a significant positive association between plasma tHcy levels and carotid-artery wall thickness in participants 55 years or older even after the tHcy levels are adjusted for age, smoking and anti-hypertensive medication. The direction and magnitude of the relationship is similar although the result was not statistically significant in younger participants ( < 55 years). Early onset CHD at any age was not significantly different across the tHcy quintiles. The lack of an association of tHcy and CHD in the presence of a positive association with intimal-medial wall thickening may be a reflection of increased statistical power of quantitative versus qualitative traits. We conclude that the present finding of a positive association between tHcy and intimal-medial wall thickness strengthens the in vitro finding of the stimulating effect of homocysteine on vascular smooth muscle cell growth. Vascular smooth muscle cell proliferation may be an important mechanism through which mildly elevated plasma tHcy promotes atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924729     DOI: 10.1016/s0021-9150(99)00409-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.

Authors:  Arpita Basu; Alicia J Jenkins; Julie A Stoner; Suzanne R Thorpe; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Timothy J Lyons
Journal:  Atherosclerosis       Date:  2014-07-15       Impact factor: 5.162

2.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism.

Authors:  Xue Dan Ke; Alexandrine Foucault-Bertaud; Cecile Genovesio; Francoise Dignat-George; Edouard Lamy; Philippe Charpiot
Journal:  Mol Cell Biochem       Date:  2009-09-29       Impact factor: 3.396

4.  MTHFR A1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians.

Authors:  Aruna Poduri; Debabrata Mukherjee; Kamal Sud; Harbir Singh Kohli; Vinay Sakhuja; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2007-09-25       Impact factor: 3.396

5.  Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism.

Authors:  Mehmet Gunduz; Ercan Gunduz; Fatih Kircelli; Nazan Okur; Mesut Ozkaya
Journal:  Int J Endocrinol       Date:  2012-02-23       Impact factor: 3.257

6.  Association of homocysteine with carotid atherosclerosis in hypertension.

Authors:  Ai Chen; Weibin Wu; Jin Gong; Ying Han; Guoyan Xu; Liangdi Xie
Journal:  J Hum Hypertens       Date:  2022-03-11       Impact factor: 2.877

7.  Tree nut consumption and prevalence of carotid artery plaques: The National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Ania Stolarczyk; R Curtis Ellison; Donna Arnett; Luc Djousse
Journal:  Eur J Nutr       Date:  2021-07-19       Impact factor: 5.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.